A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...